Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR‐DSCR) on human chromosome 21

Background Down syndrome (DS) is characterized by the presence of an extra full or partial human chromosome 21 (Hsa21). An invaluable model to define genotype‐phenotype correlations in DS is the study of the extremely rare cases of partial (segmental) trisomy 21 (PT21), the duplication of only a del...

Full description

Saved in:
Bibliographic Details
Published inMolecular genetics & genomic medicine Vol. 7; no. 8; pp. e797 - n/a
Main Authors Pelleri, Maria Chiara, Cicchini, Elena, Petersen, Michael B., Tranebjærg, Lisbeth, Mattina, Teresa, Magini, Pamela, Antonaros, Francesca, Caracausi, Maria, Vitale, Lorenza, Locatelli, Chiara, Seri, Marco, Strippoli, Pierluigi, Piovesan, Allison, Cocchi, Guido
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.08.2019
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Down syndrome (DS) is characterized by the presence of an extra full or partial human chromosome 21 (Hsa21). An invaluable model to define genotype‐phenotype correlations in DS is the study of the extremely rare cases of partial (segmental) trisomy 21 (PT21), the duplication of only a delimited region of Hsa21 associated or not to DS. A systematic retrospective reanalysis of 125 PT21 cases described up to 2015 allowed the creation of the most comprehensive PT21 map and the identification of a 34‐kb highly restricted DS critical region (HR‐DSCR) as the minimal region whose duplication is shared by all PT21 subjects diagnosed with DS. We reanalyzed at higher resolution three cases previously published and we accurately searched for any new PT21 reports in order to verify whether HR‐DSCR limits could prospectively be confirmed and possibly refined. Methods Hsa21 partial duplications of three PT21 subjects were refined by adding array‐based comparative genomic hybridization data. Seven newly described PT21 cases fulfilling stringent cytogenetic and clinical criteria have been incorporated into the PT21 integrated map. Results The PT21 map now integrates fine structure of Hsa21 sequence intervals of 132 subjects onto a common framework fully consistent with the presence of a duplicated HR‐DSCR, on distal 21q22.13 sub‐band, only in DS subjects and not in non‐DS individuals. No documented exception to the HR‐DSCR model was found. Conclusions The findings presented here further support the association of the HR‐DSCR with the diagnosis of DS, representing an unbiased validation of the original model. Further studies are needed to identify and characterize genetic determinants presumably located in the HR‐DSCR and functionally associated to the critical manifestations of DS. A systematic retrospective reanalysis of 125 PT21 cases described up to 2015 allowed the creation of the most comprehensive PT21 map and the identification of a 34‐kb highly restricted DS critical region (HR‐DSCR) as the minimal region whose duplication is shared by all PT21 subjects diagnosed with DS. We reanalyzed at higher resolution three cases previously published and we accurately searched for any new PT21 reports in order to verify whether HR‐DSCR limits could prospectively be confirmed and possibly refined.The findings presented here further support the association of the HR‐DSCR with the diagnosis of DS, representing an unbiased validation of the original model.
Bibliography:Funding information
www.radiustech.it
MCP's fellowship has been co‐funded by a donation from Fondazione Umano Progresso, Milano, Italy and by donations following the international fundraising initiative by Vittoria Aiello and Massimiliano Albanese. The fellowship for EC has been funded by Centro Universitario Cattolico, Italy. The fellowship for FA has been funded by Illumia S.p.A. (Bologna, Italy). The fellowships for MC and AP have been funded by the Fondazione Umano Progresso, Matteo and Elisa Mele and Radius S.r.l.—Technology for life
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
MCP's fellowship has been co‐funded by a donation from Fondazione Umano Progresso, Milano, Italy and by donations following the international fundraising initiative by Vittoria Aiello and Massimiliano Albanese. The fellowship for EC has been funded by Centro Universitario Cattolico, Italy. The fellowship for FA has been funded by Illumia S.p.A. (Bologna, Italy). The fellowships for MC and AP have been funded by the Fondazione Umano Progresso, Matteo and Elisa Mele and Radius S.r.l.—Technology for life (www.radiustech.it).
ISSN:2324-9269
2324-9269
DOI:10.1002/mgg3.797